Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.2 EUR | -0.10% | +3.00% | -2.68% |
05-24 | JOHNSON MATTHEY : Higher transformation costs take their toll | |
05-23 | JOHNSON MATTHEY : ICEs might stay longer |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.7 for the current year.
- This company will be of major interest to investors in search of a high dividend stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.68% | 3.71B | - | ||
+21.33% | 68.87B | A- | ||
-5.01% | 46.12B | A- | ||
+24.57% | 44.85B | B+ | ||
+32.63% | 27.9B | A- | ||
+8.44% | 19.38B | C+ | ||
+16.07% | 17.2B | B+ | ||
-10.88% | 14.68B | B+ | ||
-29.11% | 14.14B | A- | ||
+21.71% | 11.33B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- JMAT Stock
- JMT2 Stock
- Ratings Johnson Matthey Plc